CD24 and cancer: In order to assess the role of CD24-Siglec-10 signaling in regulating the immune response mediated by macrophages and the therapeutic potential of anti-CD24 monoclonal antibodies in cancer immunotherapy, we generated the humanized mAb IMM47 that targets CD24 using an internal CHO-K1 cell expression method.